1,122
Participants
Start Date
July 13, 2017
Primary Completion Date
June 15, 2019
Study Completion Date
July 15, 2019
Immunoscore test
To identify patients with high risk (IS 0-1) of relapse or death under oxaliplatin-based adjuvant therapy.
Hôpital Saint Antoine, Paris
Collaborators (1)
HalioDx
INDUSTRY
Methodology and quality of life unit in oncology, University hospital of Besancon
UNKNOWN
GERCOR - Multidisciplinary Oncology Cooperative Group
OTHER